Ralpancizumab

Tax included
Ralpancizumab is a selective PCSK9 inhibitor with potential application in hemorrhagic stroke.
MedChemExpress 
HY-P99816

Data sheet

Size
Multiple sizes
Reactivity
Ser/Thr Protease
Application
Metabolism-protein/nucleotide metabolism
CAS
1407495-04-8